2μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | IL-17RA & IL-17RC, CD217 & IL-17 RC |
| Accession | Q96F46-1、NP_703190.1 |
| Amino Acid Sequence | Leu 33-Trp 320 (IL-17 RA) with Human IgG1 Fc at the C-Terminus;Leu 21-His 465(IL-17 RC)with Human IgG1 Fc at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 100-120kDa&120-130kDa (Reducing) |
| Endotoxin | <0.1EU/μg |
| Tag | Human IgG1 Fc |
| Physical Appearance | Lyophilized powder |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation |
| Stability & Storage |
· 12 months from date of receipt,lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃under sterile conditions after reconstitution. · 1 week, 2 to 8℃under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Background
IL-17RA and IL-17RC serve as the principalreceptor subunits for IL-17 family cytokines, forming a classic heterodimericsignaling complex. Structurally, both receptors contain fibronectin type IIIdomains in their extracellular regions and engage IL-17A/F ligands via atip-to-tip assembly mode to form ternary complexes, which further organize into2:2:2 hexameric signalosomes to amplify downstream signaling. Functionally,this receptor complex drives pro-inflammatory responses through the activationof NF-κB and MAPK pathways, playing a pivotal role inthe pathogenesis of autoimmune diseases such as psoriasis and ankylosingspondylitis. Clinically, brodalumab (anti-IL-17RA) and anti-IL-17A monoclonalantibodies targeting this axis have been widely applied in the treatment ofinflammatory disorders, while small-molecule inhibitors are currently under activedevelopment.
Picture
Picture
SDS-PAGE

SEC-HPLC

The purity of IL-17 RA&IL-17 RC Heterodimer Fc&Fc Tag Protein, Human
is more than 95% as determined by SEC-HPLC.
ELISA

Immobilized IL-17F Protein, Human (Cat. No.UA040308) at 2 μg/mL (100 μL/well) can bind IL-17 RA&IL-17 RC Heterodimer Fc&Fc Tag Protein, Human (Cat. No. UA016216) with a linear range of 1.4-2.0ng/mL.

Immobilized IL-17A Protein, Human (Cat. No. UA040483) at 2 μg/mL (100 μL/well) can bind IL-17 RA&IL-17 RC Heterodimer Fc&Fc Tag Protein, Human (Cat. No. UA016216) with a linear range of 0.8-1.7ng/mL.
